This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sevier, N. Articles by Houston, M. Search for Related Content PubMed PubMed Citation Articles by Sevier, N. Articles by Houston, M. Social Bookmarking                         What's this?

Chronic Refractory ITP in Children: Beyond Splenectomy

Baylor College of Medicine, Texas Children’s Cancer Center and Hematology Service, 6701 Fannin, suite 1400, MC 3-3320, Houston, TX 77030nmsevier{at}texaschildrenshospital.org

Mary Houston, MSN, RN, CPNP

Baylor College of Medicine, Texas Children’s Cancer Center and Hematology Service, Houston, TX

Idiopathic (or immune) thrombocytopenic purpura (ITP) is a relatively common hematologic condition, but one that the hematology community has failed to reach a consensus on with regard to treatment. In patients with chronic refractory ITP, there is even less agreement about treatment approaches, as this population represents a small, but challenging, fraction of the total cases of ITP. The aim of this article is to review the treatment options available for children with chronic refractory ITP, including a review of the benefits versus risks, rate of remission, and areas of ongoing and future research.

Key Words: children • ITP • treatment • chronic refractory • pediatric • idiopathic thrombocytopenia purpura • immune thrombocytopenia purpura

Journal of Pediatric Oncology Nursing, Vol. 22, No. 3, 145-151 (2005)
DOI: 10.1177/1043454205275623


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?